tirzepatide mechanism of action gip Tirzepatide, a New Era Dual-Targeted Treatment for Diabetes and Obesity: A Mini-Review Tirzepatide for PCOS: Insulin Resistance

It activates beta-3 adrenergic receptors located in fat tissue, which triggers lipolysis (fat breakdown) without sending any signals to the brains hunger centers in the hypothalamus

Patients should monitor for signs of volume depletion, including decreased urine output, dizziness, or excessive thirst

Although more studies are still needed, the findings are creating significant interest among clinicians treating obesity-related musculoskeletal disease

anti-age

Shared Side Effects Both tirzepatide and GLP-1 medications commonly cause: Nausea Reduced appetite Fatigue during titration Digestive changes Tirzepatide-Specific Considerations Because tirzepatide affects two hormone pathways, side effects can be more dose-sensitive if titration is rushed

10.1016/j.ceca.2016.03.004 47 Krarup-HansenA.Helweg-LarsenS.SchmalbruchH.RorthM.KrarupC